QQ客服 官方微博 反馈留言

浏览/检索结果: 共4条，第1-4条 帮助 限定条件 发表日期：2021     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Discovery and structure - activity relationship exploration of pyrazolo [1,5-a]pyrimidine derivatives as potent FLT3-ITD inhibitors 期刊论文 BIOORGANIC & MEDICINAL CHEMISTRY, 2021, 卷号: 48, 页码: 13 作者:  Chen, Yun;  Bai, Gang;  Li, Yan;  Ning, Yi;  Cao, Sufen 收藏  |  浏览/下载：33/0  |  提交时间：2021/12/01 FLT3  FLT3-ITD  Acute myeloid leukemia  Structure-activity relationships  Pyrazolo[1, 5-a]pyrimidine   MD2 blockage prevents the migration and invasion of hepatocellular carcinoma cells via inhibition of the EGFR signaling pathway 期刊论文 JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021 作者:  Qi, Yajun;  Fang, Qilu;  Li, Qinglin;  Ding, Haiying;  Shu, Qi 收藏  |  浏览/下载：46/0  |  提交时间：2021/09/06 Hepatocellular carcinoma (HCC)  myeloid differentiation protein 2 (MD2)  epidermal growth factor receptor (EGFR)  migration  invasion   Discovery of a highly potent kinase inhibitor capable of overcoming multiple imatinib-resistant ABL mutants for chronic myeloid leukemia (CML) 期刊论文 EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 卷号: 897 作者:  Lu, Tingting;  Cao, Jiangyan;  Zou, Fengming;  Li, Xixiang;  Wang, Aoli 收藏  |  浏览/下载：44/0  |  提交时间：2021/04/26 BCR-ABL  ABL mutants  Chronic myeloid leukemia  Kinase inhibitor  Imatinib resistance   Adverse events associated with nilotinib in chronic myeloid leukemia: mechanisms and management strategies 期刊论文 EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2021 作者:  Wang, Zeng;  Jiang, Liyu;  Yan, Hao;  Xu, Zhifei;  Luo, Peihua 收藏  |  浏览/下载：20/0  |  提交时间：2021/04/26 Adverse events  chronic myeloid leukemia  management  mechanisms  molecular target  nilotinib